Literature DB >> 12543861

Tumor and CD4 T-cell interactions: tumor escape as result of reciprocal inactivation.

Sarah Flynn1, Brigitta Stockinger.   

Abstract

This paper addresses the capacity of naive, effector, and memory CD4 T cells to control growth of a major histocompatibility complex (MHC) class II-positive B-cell lymphoma in vivo. To assess the role of T cells on their own without contributions by B cells, antibodies, or natural killer (NK) cells, we generated pure effector or memory CD4 T cells in Rag-/-gc-/- mice deficient in endogenous lymphocytes and NK cells. Lymphoma cells expressing a model antigen were injected into mice with T cells of cognate specificity that were either naive or in effector or resting memory state. Naive T cells were unable to prevent tumor growth, probably due to delay of efficient cross-presentation by dendritic cells. However, both effector and memory T cells, dependent on the amount of antigen available, controlled the tumor for a considerable period of time without the need for dendritic cell stimulation. Nevertheless, the tumor eventually grew uncontrolled in all cases. This was not because of a defect in T-cell homing to the tumor site or loss of MHC class II or costimulatory molecules by the tumor, but reflected mutual paralysis of T-cell responsiveness and antigen processing by tumor cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12543861     DOI: 10.1182/blood-2002-10-3030

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  CD4 cells can be more efficient at tumor rejection than CD8 cells.

Authors:  Ainhoa Perez-Diez; Nathalie T Joncker; Kyungho Choi; William F N Chan; Colin C Anderson; Olivier Lantz; Polly Matzinger
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

2.  Murine models of B-cell lymphomas: promising tools for designing cancer therapies.

Authors:  Sabrina Donnou; Claire Galand; Valérie Touitou; Catherine Sautès-Fridman; Zsuzsanna Fabry; Sylvain Fisson
Journal:  Adv Hematol       Date:  2012-02-12

Review 3.  Differential role of CXCR3 in inflammation and colorectal cancer.

Authors:  Jessicca D Abron; Narendra P Singh; Angela E Murphy; Manoj K Mishra; Robert L Price; Mitzi Nagarkatti; Prakash S Nagarkatti; Udai P Singh
Journal:  Oncotarget       Date:  2018-04-03

4.  Clinical and Biological Significance of a Necroptosis-Related Gene Signature in Glioma.

Authors:  Zunjie Zhou; Jing Xu; Ning Huang; Jun Tang; Ping Ma; Yuan Cheng
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.